Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.19
-0.41 (-1.18%)
At close: Aug 28, 2026, 4:00 PM EDT
33.91
-0.28 (-0.82%)
After-hours: Aug 28, 2026, 7:58 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.46 billion as of August 28, 2026. Its market cap has increased by 75.31% in one year.
Market Cap
2.46B
Enterprise Value
2.04B
1-Year Change
75.31%
Ranking
Category
Stock Price
$34.19
ChartMarket Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.46B, an increase of 993.72%. That is a compound annual growth rate of 57.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.46B | -31.46% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.61B |
| Ultragenyx Pharmaceutical | 2.52B |
| Precigen | 2.49B |
| Pharvaris | 2.48B |
| Nektar Therapeutics | 2.48B |
| Trevi Therapeutics | 2.39B |
| Kodiak Sciences | 2.37B |
| Rapport Therapeutics | 2.34B |